BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 14716297)

  • 1. A candidate tumor suppressor HtrA1 is downregulated in ovarian cancer.
    Chien J; Staub J; Hu SI; Erickson-Johnson MR; Couch FJ; Smith DI; Crowl RM; Kaufmann SH; Shridhar V
    Oncogene; 2004 Feb; 23(8):1636-44. PubMed ID: 14716297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in mRNA and protein levels of human HtrA1, HtrA2 and HtrA3 in ovarian cancer.
    Narkiewicz J; Klasa-Mazurkiewicz D; Zurawa-Janicka D; Skorko-Glonek J; Emerich J; Lipinska B
    Clin Biochem; 2008 May; 41(7-8):561-9. PubMed ID: 18241672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serine proteases HTRA1 and HTRA3 are down-regulated with increasing grades of human endometrial cancer.
    Bowden MA; Di Nezza-Cossens LA; Jobling T; Salamonsen LA; Nie G
    Gynecol Oncol; 2006 Oct; 103(1):253-60. PubMed ID: 16650464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
    Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of underexpressed genes in early- and late-stage primary ovarian tumors by suppression subtraction hybridization.
    Shridhar V; Sen A; Chien J; Staub J; Avula R; Kovats S; Lee J; Lillie J; Smith DI
    Cancer Res; 2002 Jan; 62(1):262-70. PubMed ID: 11782386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping of a candidate colorectal cancer tumor-suppressor gene to a 900-kilobase region on the short arm of chromosome 8.
    Flanagan JM; Healey S; Young J; Whitehall V; Trott DA; Newbold RF; Chenevix-Trench G
    Genes Chromosomes Cancer; 2004 Jul; 40(3):247-60. PubMed ID: 15139003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of apoptosis in human ovarian epithelial cancer cells by antisurvivin oligonucleotides.
    Ma X; Wang S; Zhou J; Xing H; Xu G; Wang B; Chen G; Lu YP; Ma D
    Oncol Rep; 2005 Jul; 14(1):275-9. PubMed ID: 15944801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Krüppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells.
    Ito G; Uchiyama M; Kondo M; Mori S; Usami N; Maeda O; Kawabe T; Hasegawa Y; Shimokata K; Sekido Y
    Cancer Res; 2004 Jun; 64(11):3838-43. PubMed ID: 15172991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer.
    Bignone PA; Lee KY; Liu Y; Emilion G; Finch J; Soosay AE; Charnock FM; Beck S; Dunham I; Mungall AJ; Ganesan TS
    Oncogene; 2007 Feb; 26(5):683-700. PubMed ID: 16878154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the 3p12.3-pcen region associated with tumor suppression in a novel ovarian cancer cell line model genetically modified by chromosome 3 fragment transfer.
    Cody NA; Shen Z; Ripeau JS; Provencher DM; Mes-Masson AM; Chevrette M; Tonin PN
    Mol Carcinog; 2009 Dec; 48(12):1077-92. PubMed ID: 19347865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma.
    Tsai MF; Wang CC; Chang GC; Chen CY; Chen HY; Cheng CL; Yang YP; Wu CY; Shih FY; Liu CC; Lin HP; Jou YS; Lin SC; Lin CW; Chen WJ; Chan WK; Chen JJ; Yang PC
    J Natl Cancer Inst; 2006 Jun; 98(12):825-38. PubMed ID: 16788156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional evidence for an ovarian cancer tumor suppressor gene on chromosome 22 by microcell-mediated chromosome transfer.
    Kruzelock RP; Cuevas BD; Wiener JR; Xu FJ; Yu Y; Cabeza-Arvelaiz Y; Pershouse M; Lovell MM; Killary AM; Mills GB; Bast RC
    Oncogene; 2000 Dec; 19(54):6277-85. PubMed ID: 11175342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
    Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
    Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marked allelic imbalance on chromosome 5q31 does not explain alpha-catenin expression in epithelial ovarian cancer.
    Tuhkanen H; Anttila M; Kosma VM; Puolakka J; Juhola M; Heinonen S; Mannermaa A
    Gynecol Oncol; 2004 Aug; 94(2):416-21. PubMed ID: 15297182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five genes from chromosomal band 8p22 are significantly down-regulated in ovarian carcinoma: N33 and EFA6R have a potential impact on overall survival.
    Pils D; Horak P; Gleiss A; Sax C; Fabjani G; Moebus VJ; Zielinski C; Reinthaller A; Zeillinger R; Krainer M
    Cancer; 2005 Dec; 104(11):2417-29. PubMed ID: 16270321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic background of different cancer cell lines influences the gene set involved in chromosome 8 mediated breast tumor suppression.
    Seitz S; Korsching E; Weimer J; Jacobsen A; Arnold N; Meindl A; Arnold W; Gustavus D; Klebig C; Petersen I; Scherneck S
    Genes Chromosomes Cancer; 2006 Jun; 45(6):612-27. PubMed ID: 16552773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caspase-1alpha is down-regulated in human ovarian cancer cells and the overexpression of caspase-1alpha induces apoptosis.
    Feng Q; Li P; Salamanca C; Huntsman D; Leung PC; Auersperg N
    Cancer Res; 2005 Oct; 65(19):8591-6. PubMed ID: 16204022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monochromosome transfer and microarray analysis identify a critical tumor-suppressive region mapping to chromosome 13q14 and THSD1 in esophageal carcinoma.
    Ko JM; Chan PL; Yau WL; Chan HK; Chan KC; Yu ZY; Kwong FM; Miller LD; Liu ET; Yang LC; Lo PH; Stanbridge EJ; Tang JC; Srivastava G; Tsao SW; Law S; Lung ML
    Mol Cancer Res; 2008 Apr; 6(4):592-603. PubMed ID: 18403638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancer.
    Shridhar V; Bible KC; Staub J; Avula R; Lee YK; Kalli K; Huang H; Hartmann LC; Kaufmann SH; Smith DI
    Cancer Res; 2001 May; 61(10):4258-65. PubMed ID: 11358853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor suppressor effect of follistatin-like 1 in ovarian and endometrial carcinogenesis: a differential expression and functional analysis.
    Chan QK; Ngan HY; Ip PP; Liu VW; Xue WC; Cheung AN
    Carcinogenesis; 2009 Jan; 30(1):114-21. PubMed ID: 18796737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.